Cargando…
Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis
Artificial liver support systems (ALSS) are widely used to treat patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). The aims of the present study were to investigate the subgroups of patients with HBV-ACLF who may benefit from ALSS therapy, and the relevant patient-sp...
Autores principales: | Huang, Kaizhou, Ji, Feiyang, Xie, Zhongyang, Wu, Daxian, Xu, Xiaowei, Gao, Hainv, Ouyang, Xiaoxi, Xiao, Lanlan, Zhou, Menghao, Zhu, Danhua, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848208/ https://www.ncbi.nlm.nih.gov/pubmed/31712684 http://dx.doi.org/10.1038/s41598-019-53029-0 |
Ejemplares similares
-
A prognostic model for hepatitis B acute‐on‐chronic liver failure patients treated using a plasma exchange‐centered liver support system
por: Xie, Zhongyang, et al.
Publicado: (2019) -
Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen‐activated protein kinase and TLR4/nuclear factor‐κB pathways and autophagy
por: Zhang, Lingjian, et al.
Publicado: (2019) -
Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury
por: Xie, Zhongyang, et al.
Publicado: (2021) -
Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis
por: Ji, Feiyang, et al.
Publicado: (2021) -
Decreased vitamin D-binding protein level portends poor outcome in acute-on-chronic liver failure caused by hepatitis B virus
por: Wu, Daxian, et al.
Publicado: (2022)